SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
+12.89%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$245M
AUM Growth
+$245M
(+5.5%)
Cap. Flow
-$8.04M
Cap. Flow
% of AUM
-3.28%
Top 10 Holdings %
Top 10 Hldgs %
37.52%
Holding
47
New
9
Increased
11
Reduced
14
Closed
9
Top Buys
| 1 |
Tenet Healthcare
THC
|
$6.79M |
| 2 |
Elevance Health
ELV
|
$6.42M |
| 3 |
Cardinal Health
CAH
|
$5.36M |
| 4 |
Incyte
INCY
|
$5.22M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$4.83M |
Top Sells
| 1 |
PPD
PPD, Inc. Common Stock
PPD
|
$7.4M |
| 2 |
Cencora
COR
|
$5.82M |
| 3 |
Quest Diagnostics
DGX
|
$5.73M |
| 4 |
Merck
MRK
|
$4.98M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
$3.9M |
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Energy | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CTLT
26
DELISTED
CATALENT, INC.
CTLT
| $5.72M | 2.33% |
55,000
-37,500
| -41% | -$3.9M |
|
|
27
Cardinal Health
CAH
$35.8B
| $5.36M | 2.18% |
+100,000
| New | +$5.36M |
|
|
28
Incyte
INCY
$16.9B
| $5.22M | 2.13% |
+60,000
| New | +$5.22M |
|
29
Charles River Laboratories
CRL
$7.91B
| $5M | 2.04% |
20,000
-5,000
| -20% | -$1.25M |
|
30
Bio-Rad Laboratories Class A
BIO
$7.85B
| $4.66M | 1.9% |
8,000
+500
| +7% | +$292K |
|
31
Grifois
GRFS
$6.6B
| $4.61M | 1.88% |
+250,000
| New | +$4.61M |
|
32
Elanco Animal Health
ELAN
$8.89B
| $4.6M | 1.88% |
+150,000
| New | +$4.6M |
|
33
Centene
CNC
$14.5B
| $4.5M | 1.84% |
75,000
-50,000
| -40% | -$3M |
|
34
Encompass Health
EHC
$12.4B
| $3.72M | 1.52% |
45,000
-20,000
| -31% | -$1.65M |
|
35
Repligen
RGEN
$6.79B
| $2.87M | 1.17% |
+15,000
| New | +$2.87M |
|
36
Owens & Minor
OMI
$402M
| $2.71M | 1.1% |
100,000
-25,000
| -20% | -$676K |
|
37
Natera
NTRA
$23.2B
| $1.99M | 0.81% |
+20,000
| New | +$1.99M |
|
38
Adaptive Biotechnologies
ADPT
$1.96B
| $1.18M | 0.48% |
+20,000
| New | +$1.18M |
|
|
AMED
39
DELISTED
Amedisys
AMED
| – | – |
-15,000
| Closed | -$3.55M |
|
40
Biogen
BIIB
$20.3B
| – | – |
-12,000
| Closed | -$3.4M |
|
|
41
Cencora
COR
$57.4B
| – | – |
-60,000
| Closed | -$5.82M |
|
|
42
Quest Diagnostics
DGX
$20.1B
| – | – |
-50,000
| Closed | -$5.73M |
|
|
43
Merck
MRK
$212B
| – | – |
-60,000
| Closed | -$4.98M |
|
44
Select Medical
SEM
$1.61B
| – | – |
-105,000
| Closed | -$2.19M |
|
|
NUVA
45
DELISTED
NuVasive, Inc.
NUVA
| – | – |
-45,100
| Closed | -$2.19M |
|
|
LHCG
46
DELISTED
LHC Group LLC
LHCG
| – | – |
-17,500
| Closed | -$3.72M |
|
|
PPD
47
DELISTED
PPD, Inc. Common Stock
PPD
| – | – |
-200,000
| Closed | -$7.4M |
|